iPath Return on Disability ETN
RODI
RODI was delisted on the 20th of December, 2022.
2 hedge funds and large institutions have $1.08M invested in iPath Return on Disability ETN in 2020 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and closing their positions.
1% more capital invested
Capital invested by funds: $1.06M → $1.08M (+$15K)
0% more funds holding
Funds holding: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$367K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Barclays
London,
United Kingdom
| $1.08M | +$367K | +4,500 | +38% |
|
RODI Hedge Fund Activity: Q1 2020 in Review
2 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in iPath Return on Disability ETN (RODI) for Q1 2020, worth a combined $1.08M — up 1.4% from $1.06M a quarter earlier.
Fund positioning in RODI was balanced in Q1 2020: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Barclays, adding an estimated $367K.
- 2 institutional investors held iPath Return on Disability ETN (RODI) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $1.08M of iPath Return on Disability ETN stock for Q1 2020, up 1.4% quarter-over-quarter.
- 0 funds opened new iPath Return on Disability ETN positions in Q1 2020 and 0 closed out.
- The largest iPath Return on Disability ETN buyer in Q1 2020 was Barclays, an estimated $367K added.
Based on aggregated 13F filings for Q1 2020.